As a dual inhibitor of AChE and BuChE, the in vivo effect of DL0410 has been verified in a series of AD-related mouse models, including Aβ1-42-induced amnesia in mice [8] and APP/PS1 transgenic mice [12]. This evidence concerns the gene ACHE and Alzheimer disease.